Intra-arterial dantrolene for refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Neurocritical Care

Volumn 17, Issue 2, 2012, Pages 245-249

  Majidi, Shahram ^a   Grigoryan, Mikayel ^a   Tekle, Wondwossen G ^a   Qureshi, Adnan I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aneurysm; Cerebral vasospasm; Dantrolene; Subarachnoid hemorrhage

Indexed keywords

DANTROLENE; NICARDIPINE; VASODILATOR AGENT;

ADULT; ANGIOGRAPHY; ANTERIOR CEREBRAL ARTERY; ANTERIOR COMMUNICATING ARTERY ANEURYSM; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CASE REPORT; CATHETERIZATION; COIL EMBOLIZATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOLLOW UP; HEMODYNAMIC PARAMETERS; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; SUBARACHNOID HEMORRHAGE; UNSPECIFIED SIDE EFFECT;

ANGIOPLASTY, BALLOON; ANTERIOR CEREBRAL ARTERY; CEREBRAL ANGIOGRAPHY; DANTROLENE; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 84869224835     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9737-6     Document Type: Article

References (24)

1. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 2005;56:633-54; discussion 654.
2. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128-33.
3. Romero CM, Morales D, Reccius A, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11: 165-71.
4. Newell DW, Elliott JP, Eskridge JM, Winn HR. Endovascular therapy for aneurysmal vasospasm. Crit Care Clin. 1999;15:685-99. (Pubitemid 29489275)
5. Livingston K, Guterman LR, Hopkins LN. Intraarterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1993;14:346-7. (Pubitemid 23130130)
6. Frontera JA, Gowda A, Grilo C, et al. Recurrent vasospasm after endovascular treatment in subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110:117-22.
7. Liu JK, Couldwell WT. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2005;2:124-32. (Pubitemid 41270855)
8. Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schurer L, Lumenta CB. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care. 2010;12:346-51.
9. Lee KH, Lukovits T, Friedman JA. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4:68-76. (Pubitemid 43269464)
10. Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619-24. (Pubitemid 13152325)
11. McGuinness B, Gandhi D. Endovascular management of cerebral vasospasm. Neurosurg Clin N Am. 2010;21:281-90.
12. Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol. 2007;28:844-8. (Pubitemid 46776059)
13. Shah QA, Memon MZ, Suri MF, et al. Super-selective intraarterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11:190-8.
14. Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893-8. (Pubitemid 351619546)
15. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene - a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59:364-73. (Pubitemid 38489297)
16. Zhao F, Li P, Chen SR, Louis CF, Fruen BR. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem. 2001;276: 13810-6.
17. Fruen BR, Mickelson JR, Louis CF. Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem. 1997;272: 26965-71. (Pubitemid 27452649)
18. Tani E, Matsumoto T. Continuous elevation of intracellular Ca2+ is essential for the development of cerebral vasospasm. Curr Vasc Pharmacol. 2004;2:13-21. (Pubitemid 38855011)
19. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J Cereb Blood Flow Metab. 2007;27:21-32. (Pubitemid 46006581)
20. Salomone S, Soydan G, Moskowitz MA, Sims Jr. Inhibition of cerebral vasoconstriction by dantrolene and nimodipine. Neurocrit Care. 2009;10:93-102.
21. Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett. 1993;158:105-8. (Pubitemid 23261794)
22. Frandsen A, Schousboe A. Dantrolene prevents glutamate cytotoxicity and Ca2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem. 1991;56:1075-8. (Pubitemid 21922725)
23. Muehlschlegel S, Rordorf G, Bodock M, Sims Jr. Dantrolene mediates vasorelaxation in cerebral vasoconstriction: a case series. Neurocrit Care. 2009;10:116-21.
24. Muehlschlegel S, Rordorf G, Sims J. Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study. Stroke. 2011;42:1301-6.